1. Home
  2. Labeler Index
  3. Abbvie Inc.
  4. 0074-3826
  5. Product Images: Depakote ER

Product Images Depakote ER

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Depakote ER NDC 0074-3826 by Abbvie Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship and formed during the partial neutralization of valproic acid with 0.5 equivalent of sodium hydroxide. Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium has the following structure: - depakote er spl 01

Divalproex sodium is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship and formed during the partial neutralization of valproic acid with 0.5 equivalent of sodium hydroxide. Chemically it is designated as sodium hydrogen bis(2-propylpentanoate). Divalproex sodium has the following structure: - depakote er spl 01

Figure 1 - depakote er spl 02

Figure 1 - depakote er spl 02

Figure 2 - depakote er spl 03

Figure 2 - depakote er spl 03

The text appears to be a graph or chart showing the reduction in CPS rate for high dose and low dose DEPAKOTE. It is not possible to generate a useful description without further context or information.*

Figure 3 - depakote er spl 04

Figure 3 - depakote er spl 04

NDC 0074-3826-13 100 Tablets Once-Daily Dosing DEPAKOTE® ER DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS 250 mg Valproic Acid Activity Dispense the accompanying Medication Guide to each patient. Rx only abbvie - depakote er spl 05

NDC 0074-3826-13 100 Tablets Once-Daily Dosing DEPAKOTE® ER DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS 250 mg Valproic Acid Activity Dispense the accompanying Medication Guide to each patient. Rx only abbvie - depakote er spl 05

This appears to be a medication label for Depakote, containing 100 tablets with 250 mg of valproic acid each. The package insert provides prescribing information and instructions to dispense the medication in a light-resistant container and store it at a temperature between 15-30°C (59-86°F). The label also includes a National Drug Code (NDC) and a Global Trade Item Number (GTIN), as well as the manufacturer's information, AbbVie Inc. However, there are also some errors and non-English characters present in the text.*

NDC 0074-7126-11 100 Tablets TO OPEN Tear Back Along Perforation Dispense the accompanying Medication Guide to each patient. Rx only Once-Daily Dosing DEPAKOTE® ER DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS 500 mg Valproic Acid Activity Tamper-Evident: Do not accept if opened or seal has been broken. THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN - depakote er spl 06

NDC 0074-7126-11 100 Tablets TO OPEN Tear Back Along Perforation Dispense the accompanying Medication Guide to each patient. Rx only Once-Daily Dosing DEPAKOTE® ER DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS 500 mg Valproic Acid Activity Tamper-Evident: Do not accept if opened or seal has been broken. THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN - depakote er spl 06

This is a medication called DEPAKOTE® used to treat seizures, bipolar disorder, and migraine headaches. It comes in the form of extended-release tablets containing Divalproex Sodium, which is equivalent to 250 mg of Valproic Acid. The tablets should be stored in a tightly sealed, light-resistant container at a temperature of 25°C (77°F) and protected from moisture. Each bottle contains 100 tablets and should not be taken if the seal over the bottle opening is broken. For more information about proper usage, please refer to the package insert or consult with a healthcare provider.*

NDC 0074-7126-13 100 Tablets Once-Daily Dosing DEPAKOTE® ER DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS 500 mg Valproic Acid Activity Dispense the accompanying Medication Guide to each patient. Rx only abbvie - depakote er spl 07

NDC 0074-7126-13 100 Tablets Once-Daily Dosing DEPAKOTE® ER DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS 500 mg Valproic Acid Activity Dispense the accompanying Medication Guide to each patient. Rx only abbvie - depakote er spl 07

This text contains product names, and some non-alphabetic characters. It is not clear what this text refers to, so the description cannot be provided.*

depakote er spl 08

depakote er spl 08

This is a description for a medication called Depakote (divalproex sodium extended-release tablets). This medication comes in a sealed bottle and should not be used if the seal is broken. It should be stored within a specific temperature range of 15-30°C (59-86°F). Each tablet contains 500mg of Oivalproex sodium equivalent to 10Valproic acid. The manufacturer is AbbVie LTO in Barceloneta, and the prescribing information can be found in the package insert. The N product identification number is GTIN: 0300747126132.*

depakote er spl 09

depakote er spl 09

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.